Role of somatostatin analogue-based therapy in unresponsive malignant thymomas

Annals of Medicine

Volumn 31, Issue SUPPL. 2, 1999, Pages 80-85

  Palmieri, Giovannella ^a,c   Lastoria, Secondo ^b   Montella, Liliana ^a   Martignetti, Angelo ^a   Lombardi, Gaetano ^a   Salvatore, Marco ^a   Bianco, Angelo Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Lanreotide; Octreotide; Scintigrapfhy; Somatostatin; Thymoma

Indexed keywords

ANGIOPEPTIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOMYCIN; NAVELBINE; OCTREOTIDE; PACLITAXEL; PENTETREOTIDE IN 111; PREDNISONE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; VINCRISTINE;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGAMMAGLOBULINEMIA; MALE; MALIGNANT NEOPLASTIC DISEASE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS; PURE RED CELL ANEMIA; SCINTIGRAPHY; THYMOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCTREOTIDE; PEPTIDES, CYCLIC; PREDNISONE; PROGNOSIS; SOMATOSTATIN; THYMOMA; THYMUS NEOPLASMS;

EID: 0032746982     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor. Cancer 1994; 74: 606-17.
2. Wang L-S, Huang M-H, Lin T-S, Huang B-S, Chien K-Y. Malignant thymoma. Cancer 1992; 70: 443-50.
3. Sassa K, Mizushima Y, Kusajima Y, Sugiyama S, Noto H, Kobayashi M. Clinical study on thymoma: assessment of prognostic factors. Anticancer Res 1996; 16: 3895-900.
4. Göldel N, Böning L, Fredrik A, Hölzel D, Hartenstein R, Wilmanns W. Chemotherapy of invasive thymoma: a retrospective study of 22 cases. Cancer 1989; 63: 1493-500.
5. Loeherer PJ, Kim K, Aisner SC, Livingston R, Einhorn CH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southwestern Cancer Study Group. J Clin Oncol 1994; 12: 1164-8.
6. Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabro F, et al. Chemotherapy for invasive thymoma: a 13-year experience. Cancer 1991; 68: 30-3.
7. Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, et al. Thymoma. A retrospective study of 87 cases. Cancer 1994; 73: 2491-8.
8. Mornex F, Resbeut M, Richard P, Jung GM, Mirabel X, Marchai C, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. Int J Radiat Oncol Biol Phys 1995: 32: 651-9.
9. Internet PDQ clinical trial search on malignant thymoma. Http://www.cancernet.nci.nih.gov.
10. Lastoria S, Vergara E, Varrella P, Acampa W, Palmieri G, Salvatore M. In vivo detection of new neoplastic lesions expressing somatostatin receptors using In-111 octreotide. In: Rao RS, Deo MG, Sanghvi LD, Mittra I, eds. Proceedings of the XVI International Cancer Congress; 1994 Oct 30-Nov 5; New Delhi, India. Bologna, Italy: Monduzzi; 1994: 685-9.
11. Palmieri G, Lastoria S, Colao A, Vergara E, Varrella P, Biondi E, et al. Successful treatment of a patient with a thymoma and pure-red cell aplasia with octreotide and prednisone. N Engl J Med 1997; 336: 263-5.
12. Lastoria S, Vergara E, Palmieri G, Acampa V, Varrella P, Caraco C, et al. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med 1998; 39: 634-9.
13. Lin K, Nguyen BD, Ettinger DS, Chin BB. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma. Clin Nucl Med 1999; 24: 24-8.
14. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with specal reference to their clinical stages. Cancer 1981; 48: 2485-92.
15. Palmieri G, Lastoria S, Montella L, Varrella P, Martignetti A, Puto M, et al. Phase II study results of somatostatin analogs and prednisone in chemotherapy refractory thymoma patients (Abstract 1730). Proceedings of the 35th Annual Meeting of the American Society of Clinical Oncology; 1999 May 15-18; Atlanta, GA, 1999.
16. Suda T, Sugimura S, Hattori Y, Sugimura H, Kobayashi Y, Hoshino R. High-dose methylprednisolone-containing chemotherapy in advanced invasive thymoma - report of three cases (in Japanese). Jpn J Thorac Cardiovasc Surg 1998; 46: 115-20.
17. Fujisao S, Tsuda H. Th1/Th2 balance alteration in the clinical course of a patient with pure red cell aplasia and thymoma. Br J Haematol 1998; 103: 308-10.
18. Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340: 278-84.